Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > UK Business.

<< Previous

Bullboard Posts

Next >>

Comment by VerylongPLIon Oct 15, 2019 11:32am

73 Views

Post# 30231711

RE:RE:UK Business.

What I heard was VERY imminently.

stockbuphoon wrote:
That's been a rumour for quite some time. It's the only product they can sell bit it's a lumpy revenue business and it only pays 20-25% of burn at most. Maybe they sell tax losses with it and they get another year of cash to piss away?
They've dosed one patient in a trial. When will they dose another? That would be big news, eh?

VerylongPLI wrote: I was told that UK arm imminently to be sold. Anyone else hear this?